|
137
|
460
|
4nz0A |
The emcv 3dpol structure at 2.8a resolution |
|
12
|
66
|
4ov1A |
The crystal structure of a novel electron transfer ferredoxin from r. palustris haa2 |
|
146
|
402
|
4n7tA |
Crystal structure of phosphorylated phosphopentomutase from streptococcus mutans |
|
203
|
612
|
4na3A |
Crystal structure of the second ketosynthase from the bacillaene polyketide synthase bound to a hexanoyl substrate mimic |
|
156
|
683
|
4mytA |
Crystal structure of elongation factor g (efg) |
|
54
|
192
|
4ni2A |
Crystal structure of the heterodimeric catalytic domain of wild-type human soluble guanylate cyclase |
|
204
|
612
|
4na1A |
Crystal structure of the second ketosynthase from the bacillaene polyketide synthase |
|
142
|
461
|
4nlrA |
Poliovirus polymerase - c290s loop mutant |
|
41
|
172
|
4neyA |
Crystal structure of an engineered protein with ferredoxin fold, northeast structural genomics consortium (nesg) target or277 |
|
166
|
505
|
4nldA |
Crystal structure of the hepatitis c virus ns5b rna-dependent rna polymerase complex with bms-791325 also known as (1ar,12bs)-8-cyclohexyl-n-(dimethylsulfamoyl)-11-methoxy-1a-{[(1r,5s)-3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl]carbonyl}-1,1a,2,12b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide and 2-(4-fluorophenyl)-n-methyl-6-[(me |
|
33
|
167
|
4nohA |
1.5 angstrom crystal structure of putative lipoprotein from bacillus anthracis. |
|
132
|
429
|
4ofzA |
Structure of unliganded trehalose-6-phosphate phosphatase from brugia malayi |
|
135
|
461
|
4nltA |
Poliovirus polymerase - s291p loop mutant |
|
22
|
81
|
4ljmA |
Crystal structure of c-terminal rna recognition motif of human etr3 |
|
46
|
160
|
4m5nA |
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase |
|
57
|
228
|
4m63A |
Crystal structure of a filament-like actin trimer bound to the bacterial effector vopl |
|
46
|
159
|
4m5lA |
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase |
|
141
|
391
|
4lr8A |
Phosphopentomutase s154a variant soaked with ribose 5-phosphate |
|
54
|
275
|
4lubA |
X-ray structure of prephenate dehydratase from streptococcus mutans |
|
202
|
562
|
4mibA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with compound 48 (n-({(3s)-1-[6-tert-butyl-5-methoxy-8-(2-oxo-1,2-dihydropyridin-3-yl)quinolin-3-yl]pyrrolidin-3-yl}methyl)methanesulfonamide) |
|
146
|
391
|
4lrcA |
Phosphopentomutase v158l variant |
|
129
|
437
|
4mmoA |
The crystal structure of a m20 family metallo-carboxypeptidase sso-cp2 from sulfolobus solfataricus |
|
142
|
391
|
4lr7A |
Phosphopentomutase s154a variant |
|
182
|
683
|
4m1kA |
Crystal structure of elongation factor g (efg) |
|
47
|
159
|
4m5mA |
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase |
|
42
|
159
|
4m5jA |
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase |
|
18
|
94
|
4lszB |
Caspase-7 in complex with darpin d7.18 |
|
138
|
391
|
4lr9A |
Phosphopentomutase s154a variant soaked with 2,3-dideoxyribose 5-phosphate |
|
201
|
562
|
4mk9A |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 12 (n-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl}methanesulfonamide) |
|
139
|
391
|
4lreA |
Phosphopentomutase soaked with 2,3-dideoxyribose 5-phosphate |
|
162
|
458
|
4mkvA |
Structure of pisum sativum rubisco with aba |
|
101
|
428
|
4lsnB |
Crystal structure of hiv-1 reverse transcriptase in complex with (e)-3-(3-bromo-5-(4-chloro-2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj518), a non-nucleoside inhibitor |
|
101
|
425
|
4mfbB |
Crystal structure of hiv-1 reverse transcriptase in complex with 8-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)indolizine-2-carbonitrile (jlj555), a non-nucleoside inhibitor |
|
159
|
457
|
4lf2A |
Hexameric form ii rubisco from rhodopseudomonas palustris, activated and complexed with sulfate and magnesium |
|
48
|
187
|
4m5dB |
Crystal structure of the utp22 and rrp7 complex from saccharomyces cerevisiae |
|
45
|
159
|
4m5iA |
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase |
|
146
|
485
|
4lt6A |
Crystal structure of human poly(a) polymerase gamma |
|
139
|
391
|
4lraA |
Phosphopentomutase s154g variant |
|
303
|
914
|
4kc5A |
Crystal structure of the c-terminal part of rhie from burkholderia rhizoxinica |
|
204
|
562
|
4mkaA |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 13 (n-{2-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydropyridin-3-yl)phenyl]-1,3-benzoxazol-5-yl}methanesulfonamide) |
|
163
|
501
|
4lq9A |
Crystal structure of human norovirus rna-dependent rna-polymerase in complex with naf2 |
|
112
|
464
|
4mh8A |
The crystal structure of the monomeric reverse transcriptase from moloney murine leukemia virus |
|
277
|
1030
|
4k7qA |
Crystal structure of acrb complexed with linezolid at 3.5 resolution |
|
16
|
73
|
4makA |
Crystal structure of a putative ssrna endonuclease cas2, crispr adaptation protein from e.coli |
|
45
|
159
|
4m5gA |
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase |
|
45
|
159
|
4m5hA |
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase |
|
19
|
79
|
4lvoP |
Crystal structure of pfsub1-prodomain-nimp.m7 fab complex with added cacl2 |
|
144
|
391
|
4lrdA |
Phosphopentomutase 4h11 variant |
|
203
|
562
|
4mk7A |
Hepatitis c virus polymerase ns5b genotype 1b (bk) in complex with inhibitor 2 (3-(3-tert-butyl-4-methoxyphenyl)pyridin-2(1h)-one) |
|
133
|
548
|
4lslA |
Crystal structure of hiv-1 reverse transcriptase in complex with (e)-3-(3-(4-chloro-2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2h)-yl)ethoxy)phenoxy)phenyl)acrylonitrile (jlj476), a non-nucleoside inhibitor |
